Evidence map›Paper›PMID 38201016›Full record

ArticleHealthcare (Basel, Switzerland)2024

German Porphyria Registry (PoReGer)-Background and Setup.

Lea Gerischer, Mona Mainert, Nils Wohmann, Ilja Kubisch, Ulrich Stölzel, Thomas Stauch, Sabine von Wegerer, Fabian Braun, Christina Weiler-Normann, Sabine Blaschke and 3 more

Abstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Lea GerischerDepartment of Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany.ORCID 0000-0001-5746-068X
Mona MainertDepartment of Emergency Medicine and Porphyria Clinic, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12203 Berlin, Germany.
Nils WohmannDepartment of Internal Medicine II, Saxony Porphyria Center, Klinikum Chemnitz, gGmbH, 09116 Chemnitz, Germany.
Ilja KubischDepartment of Internal Medicine II, Saxony Porphyria Center, Klinikum Chemnitz, gGmbH, 09116 Chemnitz, Germany.
Ulrich StölzelDepartment of Internal Medicine II, Saxony Porphyria Center, Klinikum Chemnitz, gGmbH, 09116 Chemnitz, Germany.ORCID 0009-0008-4050-658X
Thomas StauchPorphyria Laboratory IPNET, MVZ Labor PD Dr. Med. Volkmann GbR, 76131 Karlsruhe, Germany.
Sabine von WegererPatient Organization, Berliner Leberring e.V., 12203 Berlin, Germany.
Fabian BraunMartin Zeitz Center for Rare Diseases, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.ORCID 0000-0002-4742-050X
Christina Weiler-NormannMartin Zeitz Center for Rare Diseases, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Sabine BlaschkeEmergency Department, University Medical Center Göttingen, 37075 Göttingen, Germany.
Jorge FrankDepartment of Dermatology, Venereology and Allergology, University Medical Center Göttingen, 37075 Göttingen, Germany.ORCID 0000-0003-1439-8577
Rajan SomasundaramDepartment of Emergency Medicine and Porphyria Clinic, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12203 Berlin, Germany.ORCID 0000-0003-3461-3326
Eva Diehl-WieseneckerDepartment of Emergency Medicine and Porphyria Clinic, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12203 Berlin, Germany.ORCID 0000-0002-4058-9337

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Porphyrias, as most rare diseases, are characterized by complexity and scarcity of knowledge. A national registry in one of the largest European populations that prospectively collects longitudinal clinical and laboratory data are an important and effective tool to close this gap. The German Porphyria Registry (PoReGer) was founded by four centers with longstanding expertise in the field of porphyrias and rare diseases (Charité-Universitätsmedizin Berlin, Porphyria Center Saxony Chemnitz, University Medical Center Hamburg-Eppendorf, University Medical Center Göttingen) and the German reference laboratory for porphyria, and is supported by the largest German porphyria patient organization. A specified data matrix for three subgroups (acute, chronic blistering cutaneous, acute non-blistering cutaneous) includes data on demographics, specific porphyria-related symptoms, clinical course, general medical history, necessary follow-up assessments (including laboratory and imaging results), symptomatic and disease-modifying therapies, and side-effects. Additionally, the registry includes patient-reported outcome measures on quality of life, depression, and fatigue. PoReGer aims to broaden and deepen the understanding on all porphyria-related subjects. We expect these data to significantly improve the management and care of porphyria patients. Additionally, the data can be used for educational purposes to increase awareness, for the planning of healthcare services, and for machine learning algorithms for early detection of porphyrias.

Indexed as

acute porphyriasepidemiologyporphyriarare disease registry

Identifiers

PMID38201016
PMCPMC10779132

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.